Hyaluronidase Market Worth $1,249.58 Million By 2026

The global hyaluronidase market size is expected to reach USD 1,249.58 million by 2026 growing at a CAGR of 8.55%, according to a new report by Grand View Research, Inc. The significance of minimally invasive cosmetic procedures has increased considerably over the years and various demographic research studies have been conducted to evaluate the adoption pattern of cosmetic treatments across the globe, especially in developed countries.

Hyaluronic acid fillers form the most important component of minimally invasive aesthetic procedures carried out across the globe. Since hyaluronidase is mostly preferred while conducting these procedures, a growing number of minimally invasive aesthetic surgeries are expected to positively impact market growth. Dermal fillers have significant applications in minimally invasive facial aesthetic procedures, which has also led to an increase in the number of reported complications.

Clinicians are required to be entirely aware of the symptoms associated with hyaluronic acid injection complications in order to treat them effectively. It is crucial to establish effective protocols of action suitable for emergencies wherein the desired agents are readily available at the site of surgery or treatment. This aids in controlling the adverse impact of hyaluronic acid filler injections.

Full Research Report On Hyaluronidase Market Visit Here: https://www.grandviewresearch.com/industry-analysis/hyaluronidase-market

Further key findings from the study suggest:

• Animal-derived products accounted for the largest revenue share in 2018 and are anticipated to maintain this trend throughout the forecast period
• Synthetic hyaluronidase is set to grow with a CAGR of 9.53% from 2019-2026
• Dermatology dominated among the other applications with a revenue of USD 295.81 million in 2018 and is expected to reach USD 553.62 million by 2026
• Chemotherapy is projected to be the fastest-growing application segment
• North America was the leading regional market in 2018 due to the high penetration of novel cosmetic treatments. In addition, dermatologists in this region are developing new non-surgical cosmetic procedures and hyaluronidase-based injectables which are among the highly recommended injectable dermal fillers
• Asia Pacific is projected to witness the fastest growth owing to the numerous untapped growth opportunities in hyaluronidase-based treatments
• A robust network of local manufacturers has significantly contributed to the revenue generated from this region
• Some of the key hyaluronidase market participants are Amphastar Pharmaceuticals, Inc., Halozyme Therapeutics, PrimaPharm, Inc., and Bausch & Lomb Incorporated among others

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/hyaluronidase-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Medical Image Analysis Software Market Growth & Trends

The global medical image analysis software market size is expected to reach USD 4.5 billion, expanding at a CAGR of 8.15% from 2020 to 2027, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs demand for medical image analysis software. The high growth is majorly attributed to increase in usage and uptake of image analysis solutions for diagnosis.

In addition, shifting focus to provide enhanced care has led to incorporation of various computer aided diagnosis systems, which is further contributing to the market growth. Introduction of technologically advanced products such as 3D/4D platforms and multimodality imaging platforms is also presumed to the demand for the software in the forthcoming years.

Various benefits such as flexibility and high-resolution images, along with convenient use of multi-modal integrated workflows, are expected to bolster demand and increase product penetration throughout the forecast period. Stand-alone platforms are anticipated to witness steady growth. These platforms are user-friendly and cost less as compared to integrated solutions. These solutions offer more details and features and are used by researchers, allowing them to share and access research data and analyses, thereby enhancing their ability to diagnose, research, monitor, and treat disorders. For instance, GE healthcare’s ViewPoint 6 (for MFM) is a standalone software designed for dedicated ultrasound reporting and image management.

Full Research Report On Medical Image Analysis Software Market Visit Here: https://www.grandviewresearch.com/industry-analysis/medical-image-analysis-software-market

Medical Image Analysis Software Market Report Highlights

• Standalone medical image analysis software segment is expected to witness lucrative CAGR of around 8.6% from 2020 to 2027
• On the basis of modality, the ultrasound segment is projected to ascend at a CAGR of 9.9% over the forecast period
• 3D imaging software segment is projected to expand at a CAGR of 8.8% during the forecast period
• Oncology application segment is expected to witness the fastest CAGR of 8.7% over the forecast period, owing to the increased applications of image analysis software in cancer diagnostics
• In terms of end use, hospitals held the largest revenue share in 2019 owing to increasing adoption of these systems for medical imaging in diagnosis of various diseases
• Asia Pacific is expected to showcase significant CAGR of around 8.9% owing to presence of unmet clinical needs
• The global market is fragmented in nature. Companies to witness fierce competition as the industry is technology driven
• Strategies implemented by key players include collaborative agreements, new product launches, and geographical expansion

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/medical-image-analysis-software-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Alopecia Market Size, Share, Future Growth Insights

The global alopecia market size is expected to reach USD 14.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The strong presence of pipeline products and increasing approval for laser-based therapy to treat hair loss conditions are major factors anticipated to drive growth. Moreover, rising awareness among patients about alopecia and its treatments, increasing government initiatives, supportive regulations & laws, and improvements in healthcare infrastructure are factors expected to propel market growth over the forecast period.

Technological advancements in alopecia treatment are among the key drivers of this market. There are two FDA-approved therapeutics for alopecia-Rogaine and Propecia. There has been an increase in market penetration of generics after patent expiries of both drugs. However, the launch of several promising pipeline candidates over the forecast years such as Xeljanz (tofacitinib), Breezula (clascoterone), Jakafi (ruxolitinib), SM04554, and Lumigan (Bimatoprost) is expected to substantially drive the growth of the market in the near future.

The introduction of low-level laser therapy that helps stimulate hair growth is expected to increase the treatment rate among patients facing hair loss. In addition, the launch of laser caps, helmets, combs, and bands is also anticipated to boost the market growth. For instance, Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices are some of the technologically advanced products available in the market.

Moreover, the increasing prevalence of diseases such as cancer, Polycystic Ovary Syndrome, and rheumatoid arthritis which are associated with hair loss is also expected to boost the treatment rate of hair loss in the near future. For instance, as per the U.S. Department of Health and Human Services, nearly 5 million women in the U.S. are affected by PCOS. Furthermore, according to the GBD database, the prevalence of PCOS in European countries, such as France, increased from 872,351 to 882,322 in 2018 & 2019, respectively, and in the U.K., the prevalence was found to be 1,134,082 to 1,142,498.

Market players are increasingly forming partnerships and licensing agreements to enhance their product capabilities and promote the outreach of their products. For instance, the iGrow laser system has a partnership with China Central Pharmaceuticals in China. China Central Pharmaceuticals holds exclusive distribution rights over Aspira in the country. Moreover, Capillus, LLC has collaborated with Svenson, a hair loss treatment clinic to expand the distribution of laser therapy caps in Europe and Asia Pacific region. The partnership with local players and service providers is expected to increase the adoption of innovative therapy for hair loss treatment.

Additionally, companies are actively participating in scientific conferences and conducting awareness campaigns for creating brand awareness. For instance, in February 2021, Hairmax welcomed Mary Brunetti as the brand ambassador to increase brand awareness about dealing with COVID-19-induced hair loss, as well as hereditary loss. Moreover, it plans to leverage the popularity of the brand ambassador to showcase its target market as to how its products can help regrow and revitalize their hair.

However, reimbursement remains one of the major challenges in this market. Since most of the treatment modalities are considered as not medically essential and are categorized as cosmetic procedures, the treatment for hair loss is generally not covered under insurance plans. Out-of-pocket expenses for alopecia treatment usually include prescription drug copays, frequent doctor visits, and co-insurance for procedures. Moreover, increasing adoption of substitutes, such as traditional medicines-Ayurvedic, Chinese, and herbal medications may hamper the growth of the market. Based on results from the GlaxoSmithKline plc sponsored survey, around 22.7% of the patients took Chinese medications for treating male androgenetic alopecia in South Korea followed by Taiwan with 22.0% patients.

Full Research Report On Alopecia Market Visit Here: https://www.grandviewresearch.com/industry-analysis/alopecia-market

Alopecia Market Report Highlights

• In 2020, the alopecia areata segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period
• Key late-stage pipeline candidates in the treatment of hair loss include: Xeljanz (tofacitinib), Breezula (clascoterone), and SM04554 are expected to fuel the growth in the coming years
• Alopecia universalis is anticipated to witness the fastest growth during the forecast period owing to the potential pipeline products, such as BNZ-1 (Bioniz Therapeutics), and stem cell educator therapy with minoxidil (Tianhe Stem Cell Biotechnologies, Inc.)
• North America was the largest market in 2020 mainly due to a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improved healthcare infrastructure
• Europe held the second-largest market share in 2020 given the high prevalence of AGA i.e., 80% and 50% in both the men and women of the region, respectively

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/alopecia-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Ultrasound Transducer Market Growth & Trends

The global ultrasound transducer market size is anticipated to reach USD 4.2 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.6% during the forecast period. Increasing number of product launches and growing focus of the major players on innovations for safe and accurate diagnosis are the factors driving the growth.

North America is anticipated to hold substantial share of the market during the forecast period owing to high adoption of advanced medical devices. Continuous innovations in ultrasound machine such as portable and mobile ultrasound machine is expected to fuel the growth. Moreover, presence of a large number of ultrasound transducer manufacturers is anticipated to bode well for the regional growth. These companies emphasize on heavy investments to develop smart production methods and process automation, which is a key factor in optimizing product prices and maximizing revenues.

Another innovation pertaining to these devices include burst wave lithotripsy which help delicate procedures including kidney stone destruction. The technology is not only efficient but also offers non-invasive procedure to patients, which is anticipated to ultimately augment the product demand in the forthcoming years.

Growing number of partnerships between resellers for ultrasound transducers is an emerging trend witnessed in the market. Direct purchase from Original Equipment Manufacturers (OEMs) is another trend observed in the market. End users are increasingly dealing with OEMs since they offer efficient technologies like custom strain gauge sensing to finished product designs, to achieve greater business advantage.

Full Research Report On Ultrasound Transducer Market Visit Here: https://www.grandviewresearch.com/industry-analysis/ultrasound-transducer-market

Ultrasound Transducer Market Report Highlights

• Convex transducers holds largest market share owing to the advantages of the product such as superior quality resolution for accurate diagnosis, wider footprint, and ergonometric designs
• 2D linear transducers are highly preferred as compared to 3D linear owing as they provide detailed results in heart conditions
• General imaging segment is expected to lead the ultrasound transducer market in the forthcoming years owing to increased adoption of ultrasound devices in primary diagnostic purposes
• Owing to lower labor costs and untapped areas in developing regions of Asia Pacific, the market players are expected to witness huge opportunities to increase their clientele and expand their product portfolio
• Key players in the ultrasound transducers market include Shenzhen Ruqi Technology, GE Healthcare, Siemens Healthineers, Samsung Medison, Hitachi, Esaote, Mindray, SIUI, , SonoScape Medical, FUJIFILM SonoSite, Shenzhen Jiarui Electronic Technology, and Koninklijke Philips N.V.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/ultrasound-transducer-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Oncology Clinical Trials Market Growth & Trends

The global oncology clinical trials market size is expected to reach USD 16.6 billion by 2027, expanding at a CAGR of 5.4%, according to a new report by Grand View Research, Inc. Increasing number of cancer cases and deaths due to the disease and rising demand for precision and personalized medicine to cure the disease is boosting the market growth.

The burden of cancer continues to increase due to the aging population and increasing adoption of behavioral patterns, mostly the sedentary lifestyle, dietary changes with an inclination towards junk foods, as well as smoking. In the last few years, oncology research has seen an increased focus on targeted therapies and personalized medicine. There has been a steady rise in the novel therapeutic approaches and oncology clinical trials owing to the continuous advances and shift in treatment modalities towards targeted anti-cancer drugs.

Clinical research has become an important element to address the global burden of cancer in improving the patient’s life. As per the 2019 report of IQVIA Institute for Human Data Science, out of the top 33 big pharmaceutical firms, 28 firms are developing anti-cancer molecules. The drug pipeline depicts no signs of slackening down. There are more than 600 firms that are having one or more drugs in the late-stage drug development for cancer.

Besides, the innovations in this field are also driving the market. Better insight into the etiology and classification of different types of tumors has led to a shift in the strategies of oncology treatment. Innovation is a prominent trend in oncology drug development. This is seen in the rise in the number of first-in-class drugs entering the market since 2015.

Full Research Report On Oncology Clinical Trials Market Visit Here: https://www.grandviewresearch.com/industry-analysis/oncology-clinical-trials-market

Oncology Clinical Trials Market Report Highlights

• The phase II segment dominated the market with a share of 45.8% in 2019. This is attributed to the increasing number of applications for Phase II
• The interventional design segment accounted for the largest share of 87.9% in 2019 due to the increasing number of drugs in interventional studies
• North America held 55.0% of the market share in 2019. Favorable government initiatives and the presence of a large number of players in the U.S. offering advanced services are responsible for market growth
• In Asia Pacific, the market is expected to witness the fastest CAGR of 7.4% over the forecast period, owing to the increasing patient pool and cost-efficient services.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/oncology-clinical-trials-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

U.S. Long Term Care Market Size Worth $751.9 Billion By 2027

The U.S. long term care market size is expected to reach USD 751.9 billion by 2027, expanding at a CAGR of 6.8%, according to a new report by Grand View Research, Inc. The market is expected to be driven by the rising incidence of chronic disorders in U.S., which can be attributed to a large aging population and unhealthy lifestyle. Rising prevalence of dementia, Alzheimer’s, heart disorders, respiratory diseases, and mental disorders is likely to increase the burden on long term care settings over the coming years.

According to the population projection report published by the U.S. Census Bureau in 2016, the population of millennials in U.S. is expected to surpass the population of baby boomers by 2019. As of 2016, millennials were categorized as the population aged 20 to 35 years and baby boomers were those aged between 52 and 72 years. In 2016, the population of millennials was 71 million and that of baby boomers was around 74 million. While the former will rise to 73 million in 2019, the latter will drop to 72 million. Generation X, the population group aged between 36 and 51 years, is anticipated to surpass the boomers by 2028.

Technological developments are a key characteristic of the market for long term care in U.S. In order to enhance patient quality of life, long term care facilities such as hospice have started installing wireless video-conferencing devices. These devices enable patients to access the internet from their rooms and facilitate easy communication with friends and family. These computer-based technologies have helped enhance communication between hospice nurses and caregivers and enabled them to make decisions and provide real-time solutions or “coaching tips”.

Full Research Report On U.S. Long Term Care Market Visit Here: https://www.grandviewresearch.com/industry-analysis/us-long-term-care-ltc-market

Further key findings from the study suggest:

• The nursing care segment dominated the market for long term care in U.S. in terms of revenue in 2019. This can be attributed to the presence of a large number of facilities offering medical supervision and round the clock assistance
• The hospice segment is projected to exhibit the fastest growth during the forecast period due to the increasing incidence rate of Alzheimer’s and dementia and surge in post-hospital medical assistance
• The U.S long term care Market has been witnessing several mergers and acquisitions and partnerships resulting in the integration of various services and maximizing revenue. For instance, in November 2019, the U.S. leading independent personal care, hospice, and home health company named Amedisys, Inc., signed an agreement to acquire a hospice care provider, Asana Hospice which offers service to around 540 patients daily in eight locations in Ohio, Pennsylvania, Missouri, Texas, and Kansas.
• In March 2017, Brookdale and its affiliates of Blackstone Real Estate Advisors VIII L.P. formed a venture called the Blackstone Venture, which acquired 64 senior housing communities for USD 1.1 billion
• Key players operating in the market are Brookdale Senior Living, Inc.; Sunrise Carlisle, LP; Atria Senior Living Group; Senior Care Centers of America; Amedisys, Inc., Kindred Healthcare, Inc.; Genesis Healthcare Corp.; Home Instead Senior Care, Inc.; Capital Senior Living Corporation; and Diversicare Healthcare Services, Inc.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/us-long-term-care-ltc-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Medical Device Complaint Management Market Growth & Trends

The global medical device complaint management market size is expected to reach USD 10.2 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.6% during the forecast period. Increasing use of software to support the entire complaint management process is propelling the growth.

The transition from paper-based to digital system for tracking complaints is boosting growth of the market. Incidents are recorded and the data automatically drives the investigation and resolution workflow. Companies experience more complete documentation along with the reduction in the turnaround time. The complaints management solution provides advanced analytics and reporting tools for augmented management oversight. The software also streamlines the submissions with standard reporting for the EU, FDA, Japan, Health Canada, and Australia.

For instance, the U.S. FDA encourages consumers, patients, and healthcare professionals to give voluntary reports of important adverse events, and/or product issues to MedWatch, FDA’s Safety Information and Adverse Event Reporting Program or by means of the mobile app known as MedWatcher. The app radically simplifies and accelerates the process of reporting by providing users with a four-step form submitted electronically to the FDA.

Regulators are gradually concentrating on handling customer complaints, product safety, and device vigilance. This is not only true in developed countries, but also in emerging economies such as India. The Indian government introduced medical devices regulation program, Materiovigilance Programme of India (MvPI) with focus on safety data collection, synchronization of international laws, regulations, and standards encourages medical device organizations to evaluate their existing procedures of product development and post-marketing surveillance.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/medical-device-complaint-management-market

Medical Device Complaint Management Market Report Highlights

• Product surveillance and regulatory compliance emerged as the largest segment owing to greater emphasis put on product surveillance by regulatory agencies
• North America held the largest market share in 2017 owing to stern regulatory requirements and heavy monetary fines in this region. All the device manufacturers, importers, and distributors are required to comply with the complaint and record requirement
• Some of the key players operating in the medical device complaint management market include IQVIA, Wipro, Tata Consulting Services, SAS, Sparta Systems, Parexel International Corporation, Biovia, AssurX, MasterControl, and Freyr.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/medical-device-complaint-management-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Healthcare Staffing Market Future Growth & Trends

The global healthcare staffing market size is likely to reach USD 48.6 billion by 2027 at a CAGR of 5.4% over the forecast period, based on a new report by Grand View Research, Inc. The rising demand for temporary nursing staff especially due to growing geriatric population is boosting the scope for these services across the world.

In 2010, the Association of American Medical Colleges estimated that U.S. might face a shortfall of 150,000 doctors during the next 10-15 years. In August 2019, the National Association of Locum Tenens Organizations (NALTO) stated that 90% of the U.S. healthcare facilities use locum tenens providers and over 50,000 physicians work on locum tenens projects every year. The increasing number of physicians choosing to work as locum tenens is expected to propel the market growth over the forecast period.

Furthermore, the hospitals are forced to reduce the staff and implement policies for ensuring the availability of nurses upon an increase in the workload, in response to the pressure of costs. Due to high penetration of the market, there is the availability of healthcare staff during emergencies, thereby driving the market growth.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/healthcare-staffing-market

Healthcare Staffing Market Report Highlights

• By service, the market has been segmented into travel nurse, per diem nurse, locum tenens, and allied healthcare, out of which, the travel nurse segment dominated the market in terms of revenue share in 2019
• Locum tenens are anticipated to witness a significant growth rate over the forecast period owing to rising number of physicians opting to work as locum tenens and due to the cost-effectiveness to the providers
• North America held a majority of the market share in 2019 due to shortage of skilled professionals in the region, local presence of several market players, and overall growth in geriatric population
• Asia Pacific is expected to register the highest growth rate over the forecast period due to increasing awareness regarding contract staffing, promising economic outlook, and increasing investments by various market players
• Some of the key players operating in the healthcare staffing market are AMN Healthcare; Envision Healthcare Corporation; Maxim Healthcare Services, Inc.; CHG Management, Inc.; inVentiv Health; Cross Country Healthcare, Inc.; TeamHealth; Adecco Group; and Almost Family.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/healthcare-staffing-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Robotic Prosthetic Market Future Growth, Demand And Business Scope

The global robotic prosthetic market size is anticipated to reach USD 2.1 billion by 2027, expanding at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Increasing cases of amputation, advancements in robotic space, and a rise in the number of ulcers, diabetes, and congenital abnormalities that lead to amputation are estimated to drive growth over the forecast period. Moreover, increasing government funding and innovations in robotic space are anticipated to drive growth over the forecast period.

Based on technology used, the market is segmented into MPC Prosthetics and Myoelectrical Prosthetics. MPC technology dominated the market in 2019, and is forecasted to grow at a lucrative rate over the forecast period. Whereas, Myoelectrical prosthetics is anticipated to be the fastest-growing segment during the forecast period. The prosthetics operate on electric power, without putting any extra stress or muscle tension on the wearer. This advantage of Myoelectrical technology over MPC is anticipated to drive segment growth over the forecast period.

Based on the extremity, the robotic prosthetic market is segmented into upper extremity and lower extremity. Lower extremity dominated the market in 2019, and is also expected to grow at the fastest rate over the forecast period. Increasing amputations of the lower limb owing to the high incidence of the diabetic foot and vascular diseases are anticipated to drive segment growth. Moreover, the launch of innovative products by major players is further anticipated to drive growth over the forecast period.

North America dominated the market in 2019, with a revenue share of 43.5%. Major factors driving the growth are increasing healthcare expenditure, improvements in robotic space and favorable government initiatives with regards to supporting robotic technology in U.S. are the major factors driving the growth. Asia Pacific is anticipated to be the fastest-growing region, owing to the growing investments in the robotic field and rising healthcare expenditure.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/robotic-prosthetics-market

Further key findings from the report suggest:

• The market is anticipated to reach USD 2.07 billion by 2027, owing to the advancements in robotic space
• The myoelectric prosthetics segment is expected to be the fastest growing with a CAGR of 10.3%, as it operates on electric power without stressing the wearer
• Lower extremity dominated the space in 2019 with a CAGR of 9.5%, owing to the increasing number of lower limb amputation and growing prevalence of diabetic foot
• North America dominated the robotic prosthetic market in 2019 with a value of USD 454.9 million, as the adoption of technologically advanced products in the region is high
• Some of the key players are Ottobock; Touch Bionics, Inc.; Shadow Robot Company; and HDT Global.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/robotic-prosthetics-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Mobile Cardiac Telemetry Systems Market Growth & Trends

The global mobile cardiac telemetry systems market size is expected to reach USD 1.58 billion by 2027, registering a CAGR of 11.3% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorder, need for effective arrhythmia management, and technological advancement in telemetry devices are driving the market growth.

Increasing demand for real-time cardiac monitoring and self-care management are boosting the demand for mobile cardiac telemetry devices. In addition, presence of advanced healthcare infrastructure, high disposable income in the developed countries is further propelling the revenue. Moreover, these devices found to be helpful in monitoring COVID-19 patients taking azithromycin and hydroxychloroquine medication which is expected to boost the market revenue. The market is technology driven and the key industry players are continuously trying to develop user friendly devices to sustain their market share.

In April 2020, Medicomp, Inc. partnered with the Lenox Hill Hospital to monitor heart's electrical conduction of COVID-19 patients with certain medication by its TelePatch- Mobile Cardiac Telemetry (MCT), which is expected to increase the adoption of this device in the forthcoming years

For more info visit here: https://www.grandviewresearch.com/industry-analysis/mobile-cardiac-telemetry-systems-market

Mobile Cardiac Telemetry Systems Market Report Highlights

• In terms of revenue, lead based dominated the application segment in 2019 owing to its accuracy and ease of use. Moreover, the product is cost-effective as compared to patch-based which is further propelling the demand
• Patch based segment is expected to show lucrative growth over the forecast period. The growth can be attributed to its increased adoption in outpatient facilities and ambulatory centers
• On basis of end use, hospitals held the largest revenue share in 2019 owing to increased number of minimally invasive surgeries within these facilities
• The cardiac centers segment is expected to witness the fastest growth over the forecast period owing to its associated advantages such as reduced wait times, availability of skilled professionals and shorter stay duration

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/mobile-cardiac-telemetry-systems-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com